Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose ChemotherapyFrits S.A.M. van Dam, Sjoerd Rodenhuis, Martin Müller et al.|JNCI Journal of the National Cancer Institute|1998Cited by 768
Late effects of adjuvant chemotherapy on cognitive function:a follow-up study in breast cancer patientsSanne B. Schagen, F.S.A.M. van Dam, Martin Müller et al.|Annals of Oncology|2002Cited by 260
The Amsterdam Preoperative Anxiety and Information Scale (APAIS)Nelly Moerman, Hans Oosting, Frits S.A.M. van Dam et al.|Anesthesia & Analgesia|1996Cited by 172
In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptideUlrike Krauss, Annette G. Beck‐Sickinger, Michael Ståhl et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 39